Hemobiotech Inc (HMBT)

Ticker: HMBT


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Nino Ghassan Non-Executive Director Large shareholder
Transaction date
Sale
Price
477.67
Quantity 92,104 -39.6%
Value US$3,458,484
Baron Robert Non-Executive Director
Transaction date
Purchase
Price
29.54
Quantity 48,574 -27.0%
Value US$2,075,231
Baron Robert Non-Executive Director
Transaction date
Purchase
Price
64.38
Quantity 19,706 -5.5%
Value US$1,568,337
Baron Robert Non-Executive Director
Transaction date
Purchase
Price
1.95
Quantity 5,000 +23.1%
Value US$9,750
Rosenblum Mark J Chief Financial Officer Officer
Transaction date
Purchase
Price
1.50
Quantity 2,000 +inf%
Value US$3,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2007-03-16 2007-03-14 S Sale Nino Ghassan Non-Executive Director Large shareholder
92,104 -39.6%
477.67
US$3,458,484
92,104 -39.6% 477.67 US$3,458,484
2006-03-21 2006-03-20 B Purchase Baron Robert Non-Executive Director
48,574 -27.0%
29.54
US$2,075,231
48,574 -27.0% 29.54 US$2,075,231
2006-03-21 2006-03-17 B Purchase Baron Robert Non-Executive Director
19,706 -5.5%
64.38
US$1,568,337
19,706 -5.5% 64.38 US$1,568,337
2006-02-27 2006-02-23 B Purchase Baron Robert Non-Executive Director
5,000 +23.1%
1.95
US$9,750
5,000 +23.1% 1.95 US$9,750
2005-11-23 2005-11-21 B Purchase Rosenblum Mark J

Chief Financial Officer

Officer
2,000 +inf%
1.50
US$3,000
2,000 +inf% 1.50 US$3,000
Explore more

More insider trading research around Hemobiotech Inc